The originating document has been archived. We cannot confirm the completeness, accuracy and currency of the content.
Neomycin Sulfate / Polymyxin B Sulfate / Gramicidin
Pronunciation: NEE-oh-MY-sin SULL-fate/pahl-ee-MIX-in BEE SULL-fate/gram-ih-SIGH-din
- Ophthalmic Solution 10,000 units/mL polymyxin B sulfate, 1.75 mg/mL neomycin, and 0.025 mg/mL gramicidin
Optimyxin Plus Solution (Canada)
Inhibits protein synthesis by binding to ribosomal RNA, causing bacterial genetic code misreading.Polymyxin B
Interacts with phospholipid components of bacterial cell membranes, increasing cell wall permeability.Gramicidin
Increases the permeability of the bacterial cell wall to inorganic cations by forming a network of channels through the normal lipid bilayer of the membrane.
Indications and Usage
Topical treatment of superficial infections of the external eye and its adnexa caused by susceptible bacteria.
Hypersensitivity to any component of the product.
Dosage and AdministrationAdults
Ophthalmic Instill 1 or 2 drops into the affected eye every 4 h for 7 to 10 days. In severe infections, the dosage may be increased to as many as 2 drops every h.
- For ophthalmic use only. Not for use in the ears or on the skin.
- Do not allow tip of dropper bottle to touch eye, eyelid, fingers, or any other surface.
- If using other topical ophthalmic medications, instill drops first, wait at least 5 min, and instill ointment last.
Store at controlled room temperature (59° to 86°F). Keep bottle tightly capped and protect from light.
None well documented.
Laboratory Test Interactions
None well documented.
Hypersensitivity, including itching, swelling, and conjunctival erythema; local irritation.
Allergic hypersensitivity, including anaphylaxis.
Category C .
Safety and efficacy not established.
Prolonged use may result in bacterial or fungal overgrowth of nonsusceptible microorganisms.
Has been reported with use of topical ophthalmic products in multiple-dose containers that have been inadvertently contaminated by patients who frequently had concurrent corneal disease or a disruption of the ocular epithelial surface.
Allergic cross-sensitivity to kanamycin, paromomycin, streptomycin, and possible gentamicin may occur.
- Review prescribed dosing schedule with patient, family, or caregiver.
- Remind patient, family, or caregiver that solution is for use in the eye only.
- Teach patient, family, or caregiver proper technique for instilling solution: wash hands; do not allow tip of dropper bottle to touch eye, eyelid, fingers, or any other surface. Tilt head back and look up; pull lower eyelid down to form pocket; place prescribed number of drops in the pocket. Look downward before closing eye. Do not rub eye.
- Advise patient, family, or caregiver that if more than 1 topical ophthalmic drug is being used, instill eye drops first, wait at least 5 min, and then instill ointment last.
- Inform patient that temporary blurred vision and stinging of the eye are the most common adverse reactions and to contact health care provider if they occur and are bothersome.
- Advise patient to contact eye doctor if eye or eyelid inflammation is noted or if eye symptoms do not improve or worsen.
- Advise patient that the entire course of therapy must be completed to ensure max benefit and to complete full course of therapy even if symptoms have resolved.
- Instruct patient not to wear contact lenses during treatment.
- Remind patient, family, or caregiver that follow-up eye examinations may be necessary while using this medication and to keep appointments.
Copyright © 2009 Wolters Kluwer Health.